过去一年中添加的文章,按日期排序
[HTML][HTML] … of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients
NC van der Merwe, I Buccimazza, B Rossouw… - Breast Cancer Research …, 2024 - Springer
8 天前 - … studies are warranted to determine whether clinical decision-making is affected by
the … all the patients reported a family history of breast and/or various cancer types, Cases 5&6 …
the … all the patients reported a family history of breast and/or various cancer types, Cases 5&6 …
Association of childhood trauma with choice of bilateral mastectomy for the treatment of unilateral breast cancer.
AD Jagielo, C Benedict, N Zewde, E Neri, B Nouriani… - 2024 - ascopubs.org
8 天前 - … trauma in relation to treatment decision-making in adulthood within a sample of
breast cancer patients undergoing either BMX or more conservative BC treatment. Methods: …
breast cancer patients undergoing either BMX or more conservative BC treatment. Methods: …
Decision-making concordance: A comparative analysis between a multidisciplinary tumor board and a large language model (ChatGPT) in breast cancer …
ER Torres-Cisneros, M Canavati-Marcos… - 2024 - ascopubs.org
9 天前 - … Methods: This study included 124 patients discussed at our Tumor Board from March
… 33% of patients meet the NCCN criteria for a family history of cancer. The distribution of …
… 33% of patients meet the NCCN criteria for a family history of cancer. The distribution of …
Roll out and influence of an educational program: Talking about risk, uncertainties of testing in genetics (TRUSTING).
VA Jenkins, R Habibi, V Hall, P Leonard, A Lawn… - 2024 - ascopubs.org
9 天前 - … Background: Family history clinics face significant capacity issues making calls for
genetic testing of all breast cancer (BC) patients problematic. Mainstreaming of services by …
genetic testing of all breast cancer (BC) patients problematic. Mainstreaming of services by …
Treatment of HER2 positive stage 4 breast cancer: When to stop anti-HER2 agents.
Y Kamada, N Takigami, K Uehara, K Tamaki, N Tamaki - 2024 - ascopubs.org
9 天前 - … of treatment of stage 4 breast cancer has been prolongation of live without compromising
the quality of life of the patient and family. … , miRNA) might facilitate decision making. …
the quality of life of the patient and family. … , miRNA) might facilitate decision making. …
Basal cell carcinomas of the areola-nipple complex: Case report and review of the literature
A Mouadin, L Tahiri El Ousrouti… - … Open Medical Case …, 2024 - journals.sagepub.com
17 天前 - … treatment guidelines complicates clinical decision-making. Herein, we present a rare
case of basal cell carcinoma … The patient had a family history of breast cancer in her aunt. …
case of basal cell carcinoma … The patient had a family history of breast cancer in her aunt. …
Abstract PO2-26-03: Patient decision making and preferences regarding neoadjuvant chemotherapy in Mexican women with early breast cancer
Y Chavarri-Guerra, HC Verduzco-Aguirre… - Cancer Research, 2024 - AACR
36 天前 - … In 75.8% of the cases the oncologist made the decision of NAC and in 96.5%
the chemotherapy schedule was explained to patients and their families. 82.7% of women …
the chemotherapy schedule was explained to patients and their families. 82.7% of women …
Neuroendocrine Breast Tumors: Could Multigene Assays Help in Guiding Treatment Decisions? Case Presentation
C Markopoulos, N Tsoulos, K Agiannitopoulos… - in vivo, 2024 - iv.iiarjournals.org
45 天前 - … profiling and assist in clinical decision making. The aim of the … recurrence of breast
cancer, regardless of treatment. These … women with no family history of breast cancer. All …
cancer, regardless of treatment. These … women with no family history of breast cancer. All …
[HTML][HTML] Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers
X Yang, TM Mooij, G Leslie, L Ficorella… - Journal of Medical …, 2024 - jmg.bmj.com
45 天前 - … in predicting 5-year breast cancer risks in a prospective … However, BC risks for PV
carriers vary by family history (FH) and by … To exclude patients with potentially prevalent but …
carriers vary by family history (FH) and by … To exclude patients with potentially prevalent but …
[HTML][HTML] Corrigendum: Neutrophil to lymphocyte ratio and principal component analysis offer prognostic advantage for dogs with mammary tumors
E Uribe-Querol, L Romero-Romero… - Frontiers in Veterinary …, 2024 - frontiersin.org
57 天前 - … In dogs, mammary cancer is multifactorial with various … Cancer is the leading cause
of death among family dogs, … to improve the decision making regarding possible treatments.…
of death among family dogs, … to improve the decision making regarding possible treatments.…